Applied DNA Signs 5-Year Agreement with Iconic Writing Instrument Specialist Montblanc-Simplo GMBH to Provide SigNature® DNA...
July 02 2019 - 9:25AM
Business Wire
Five-year
Agreement to supply Applied DNA Unique Marks for use in a range of
Montblanc inks for use in writing instruments
Applied DNA Sciences Inc. (NASDAQ: APDN) (“Applied
DNA”, the “Company”), a leader in PCR-based DNA manufacturing for
product authenticity and traceability solutions, announced today
the signing of a five-year Agreement with Germany-based
Montblanc-Simplo GMBH (“Montblanc”) for the provision of unique
SigNature® DNA marks for individual Montblanc clients.
This Agreement culminates a rigorous 18-month product
development and qualification program between Applied DNA and
Montblanc for SigNature DNA with Beacon® in a range of specialist
inks for use in the high-end range of Montblanc writing
instruments. The SigNature DNA molecular tag provides the forensic
evidence for traceability; Beacon is a covert screening feature of
the SigNature DNA molecular tag, fluorescing only with
complementary decryptant.
Under the terms of the Agreement, Applied DNA will supply a
minimum number of its Signature DNA marks combined with Beacon for
use by Montblanc clients on a 2-year exclusive basis.
Dr. James Hayward, president and CEO of Applied DNA, said, “We
had a shared vision with Montblanc that our SigNature DNA with
Beacon could be supplied to Montblanc clients who may wish to
forensically prove a document had been signed using a personally
unique molecular tag. We are pleased to announce this has been
achieved and will soon be made available by Montblanc, initially to
an exclusive list of their clients.”
Paolo Della Chiesa Poma, Junior Product Manager at Montblanc,
said “We are very pleased to be able to offer this very unique and
novel solution for our discerning clients following thorough and
rigorous testing over many months.”
About Montblanc
Montblanc, synonymous with exquisite writing culture for the
past 100 years, follows lasting values such as quality and
traditional craftsmanship. Its uncompromising demands on shape,
style, materials and workmanship are reflected in all its products.
Founded in 1906 the Hamburg based company are renowned for their
high quality and fashionable writing instruments, timepieces,
leather goods amongst other high-end products.
About Applied DNA Sciences
Applied DNA is a provider of molecular technologies that enable
supply chain security, anti-counterfeiting and anti-theft
technology, product genotyping and DNA mass production for
diagnostics and pre-clinical personalized medicine and
therapeutics.
Applied DNA makes life real and safe by providing innovative,
molecular-based technology solutions and services that can help
protect products, brands, entire supply chains, and intellectual
property of companies, governments and consumers from theft,
counterfeiting, fraud and diversion.
Visit adnas.com for more information. Follow us on Twitter and
LinkedIn. Join our mailing list.
Common stock listed on NASDAQ under the symbol APDN, and
warrants are listed under the symbol APDNW.
Forward-Looking Statements
The statements made by Applied DNA in this press release may be
“forward-looking” in nature within the meaning of the Private
Securities Litigation Act of 1995. Forward-looking statements
describe Applied DNA’s future plans, projections, strategies and
expectations, and are based on assumptions and involve a number of
risks and uncertainties, many of which are beyond the control of
Applied DNA. Actual results could differ materially from those
projected due to its history of net losses, limited financial
resources, limited market acceptance, ability to maintain its
NASDAQ listing and various other factors detailed from time to time
in Applied DNA’s SEC reports and filings, including our Annual
Report on Form 10-K filed on December 18, 2018 and our subsequent
quarterly reports on Form 10-Q filed on February 7, 2019 and May 9,
2019, and other reports we file with the SEC, which are available
at www.sec.gov. Applied DNA undertakes no obligation to update
publicly any forward-looking statements to reflect new information,
events or circumstances after the date hereof to reflect the
occurrence of unanticipated events, unless otherwise required by
law.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190702005081/en/
Investors: Sanjay M. Hurry, LHA Investor Relations,
212-838-3777, shurry@lhai.com Media: Meryl Rader,
781-639-4924, meryl@cgprpublicrelations.com Program: Tony
Benson, 44 (0) 7552 429341, tony.benson@adnas.com
Web: www.adnas.com Twitter: @apdn
Applied DNA Sciences (NASDAQ:APDN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Applied DNA Sciences (NASDAQ:APDN)
Historical Stock Chart
From Apr 2023 to Apr 2024